
Please try another search
Stella Diagnostics, Inc., a research diagnostics company, engages in developing molecular diagnostics tools and new drug targets for esophageal diseases. It uses targeted mass spectrometry to determine the level of disease progression in tissue of the lower esophagus. The company’s technology notifies gastroenterologists, surgical oncologists, and pathologists, which patients are high risk for disease progression into precancer or cancer. The company was formerly known as JMP Properties, Inc. and changed its name to Stella Diagnostics, Inc. in April 2021. Stella Diagnostics, Inc. is headquartered in Salt Lake City, Utah.
Name | Age | Since | Title |
---|---|---|---|
Peter Anthony Cohen | 78 | 2021 | Director |
Seth Phillip Platt | - | - | Director |
Daniel Wainstein | - | - | Chairman of the Board |
David B. Seaburg | 55 | 2021 | CEO & Director |
Fredric Zaino | - | - | Director |
Marissa Welner | - | 2021 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review